Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marlene Hamilton"'
Autor:
Kurt Ebeling, Peng Wang, Elena Liew, Nancy Zhu, Mark Hnatiuk, Minakshi S. Taparia, Marlene Hamilton, Joseph Brandwein
Publikováno v:
Blood. 140:11636-11637
Autor:
Minakshi Taparia, Nancy Zhu, Aniket Bankar, Marlene Hamilton, Joseph Brandwein, Jeffrey M. Patterson, Tiffany Van Slyke, Elena Liew, Lauren Bolster, Lalit Saini, Mohammad Karkhaneh, Cynthia Wu, Darren Hallett
Publikováno v:
American Journal of Hematology. 96
Publikováno v:
Cultural and Pedagogical Inquiry. 11
en
Autor:
Loree Larratt, Elena Liew, Nancy Zhu, Joseph Brandwein, Sunita Ghosh, Lauren Bolster, Anthea Peters, Robert Turner, Lalit Saini, Jeffery M. Patterson, Marlene Hamilton, Bruce Ritchie, Cynthia Wu, Irwindeep Sandhu, Michael J. Mant
Publikováno v:
European journal of haematology. 97(5)
We conducted a retrospective study assessing FLAG (fludarabine, cytarabine, and granulocyte colony-stimulating factor) as first-line treatment in 56 newly diagnosed acute myeloid leukemia patients considered ineligible for anthracycline-based treatme
Autor:
Minakshi Taparia, Irwindeep Sandhu, Graeme R. Quest, Lalit Saini, Robert Turner, Elena Liew, Imran Mirza, Bruce Ritchie, Cynthia Wu, Loree Larratt, Sunita Ghosh, Michael J. Mant, Marlene Hamilton, Susan Nahirniak, Lauren Bolster, Jeffery M. Patterson, Nancy Zhu, Anthea Peters, Joseph Brandwein
Publikováno v:
Leukemia research. 45
Most guidelines suggest that only the bone marrow aspirate (BMA) is necessary to assess residual disease following intensive chemotherapy for Acute Myeloid Leukemia (AML) with the bone marrow trephine biopsy (BMTB) recommended in cases of a poor qual
Publikováno v:
Leukemia & Lymphoma. 56:2203-2205
Publikováno v:
American Journal of Clinical Oncology. 27:364-368
Capecitabine is a novel oral chemotherapy agent designed to generate 5-fluorouracil (5-FU) preferentially in tumor tissue, and is the most effective therapy for anthracycline and taxane-resistant breast cancer. Macrocytosis has not been previously re
Publikováno v:
Thrombosis research. 112(1-2)
Marlene A. Hamilton, Linda Stang, Wai S. Etches, Robert Rennie, Michael J. Mant* 2E3.32 Walter C. MacKenzie Health Sciences Centre, Department of Medicine, University of Alberta and University of Alberta Hospital, Edmonton, Alberta, Canada T6G 2R7 De
Autor:
Lauren Bolster, Anthea Peters, Nancy Zhu, Bruce Ritchie, Joseph Brandwein, Robert Turner, Cynthia Wu, Elena Liew, Graeme R. Quest, Sunita Gosh, Lalit Saini, Imran Mirza, Loree Larratt, Michael J. Mant, Irwindeep Sandhu, Jeffery M. Patterson, Marlene Hamilton, Susan Nahirniak
Publikováno v:
Blood. 124:2336-2336
Background: The diagnosis of acute myeloid leukemia (AML), response to treatment and disease recurrence are most commonly assessed with bone marrow studies. Recommendations from leading experts (Bain, 2001) and guidelines of the European LeukemiaNET
Autor:
Michael J. Mant, Lauren Bolster, Nancy Zhu, Marlene Hamilton, Anthea Peters, Joseph Brandwein, Sunita Gosh, Irwindeep Sandhu, Jeffery M. Patterson, Imran Mirza, Robert Turner, Loree Larratt, Graeme R. Quest, Lalit Saini, Elena Liew, Bruce Ritchie, Cynthia Wu
Publikováno v:
Blood. 124:961-961
BACKGROUND: Anthracycline based treatment for acute myeloid leukemia (AML) can be associated with significant morbidity and mortality amongst older patients or those with significant co-morbidities. Furthermore, for patients with previous anthracycli